World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
27446
World Ranking
1872
National Ranking
914

Overview

Mark K. Louder is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research focuses extensively on immunology, microbiology, and medicine with an emphasis on infectious diseases and virology.

Their work is represented across multiple fields, notably:

  • Immunology and Microbiology
  • Medicine

Subfields within these broader categories include:

  • Virology
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology
  • Immunology
  • Infectious Diseases

Their research contributions span a range of topics, such as:

  • HIV Research and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • Glycosylation and Glycoproteins Research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Vaccines and Immunoinformatics Approaches
  • HIV/AIDS Drug Development and Treatment

Mark K. Louder has published frequently in several scientific venues. Key publication sources include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell Reports
  • UNC Libraries
  • mAbs
  • Nature Communications

Selected recent papers authored or co-authored by Mark K. Louder encompass:

  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness (2020, Nature)
  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020, New England Journal of Medicine)
  • SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness (2020, bioRxiv)
  • Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth (2020, Science)
  • Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition (2020, Cell Reports)

Collaborations with several co-authors occur recurrently, including:

  • Nicole A. Doria-Rose
  • Peter D. Kwong
  • Bob C. Lin
  • John R. Mascola
  • Baoshan Zhang

Best Publications

  • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp

  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.

    Kizzmekia S. Corbett;Darin K. Edwards;Sarah R. Leist;Olubukola M. Abiona

  • Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

    John R. Mascola;Mark G. Lewis;Gabriela Stiegler;Dawn Harris

  • Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

    Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman

  • Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    Jinghe Huang;Gilad Ofek;Leo Laub;Mark K. Louder

  • Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    John R. Mascola;Gary Nabel;Barton F. Haynes;Xueling Wu

  • Human skin Langerhans cells are targets of dengue virus infection.

    Shuenn-Jue L. Wu;Geraldine Grouard-Vogel;Wellington Sun;John R. Mascola

  • Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    Marie Pancera;Tongqing Zhou;Aliaksandr Druz;Ivelin S. Georgiev

  • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

    Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  • Broad HIV-1 neutralization mediated by CD4-binding site antibodies

    Yuxing Li;Stephen A Migueles;Brent Welcher;Krisha Svehla

  • Overexpression of nef as a marker for restricted HIV‐1 infection of astrocytes in postmortem pediatric central nervous tissues

    Y. Saito;L. R. Sharer;L. G. Epstein;J. Michaels

  • Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies.

    Tongqing Zhou;Jiang Zhu;Xueling Wu;Stephanie Moquin

  • Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

    Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

  • Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    Young Do Kwon;Marie Pancera;Priyamvada Acharya;Ivelin S. Georgiev

  • Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    Rui Kong;Kai Xu;Tongqing Zhou;Priyamvada Acharya

  • Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16

    Marie Pancera;Syed Shahzad-Ul-Hussan;Nicole A. Doria-Rose;Jason S. McLellan

  • Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors

    Tongqing Zhou;Rebecca M. Lynch;Lei Chen;Priyamvada Acharya

  • Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    Mattia Bonsignori;Tongqing Zhou;Zizhang Sheng;Lei Chen

  • Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals

    Yuxing Li;Krisha Svehla;Mark K. Louder;Diane Wycuff

Frequent Co-Authors

John R. Mascola
John R. Mascola ModeX Therapeutics
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases
Nicole A. Doria-Rose
Nicole A. Doria-Rose National Institute of Allergy and Infectious Diseases
Krisha McKee
Krisha McKee National Institute of Allergy and Infectious Diseases
Sijy O'Dell
Sijy O'Dell National Institute of Allergy and Infectious Diseases
Gwo-Yu Chuang
Gwo-Yu Chuang Moderna Therapeutics (United States)
Lawrence Shapiro
Lawrence Shapiro Columbia University
Ivelin S. Georgiev
Ivelin S. Georgiev Vanderbilt University Medical Center
Tongqing Zhou
Tongqing Zhou National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open doors to diverse career options. Accelerated nursing programs, such as the easiest absn to get into, offer a fast track into nursing, blending science and patient care—an excellent foundation for Immunology-related roles.

Nursing careers can also begin with foundational programs like which lpn programs are easiest to get into. These pathways provide essential clinical skills and experience, which are valuable when moving toward specialized fields such as Immunology and infectious disease management.

For advanced practice, the easiest np program options are appealing for nurses aiming to deepen their clinical expertise while maintaining flexibility with online learning. This can complement an Immunology background when focusing on patient care in immune-related disorders.

Mental health is also closely tied to immune function, making pmhnp programs online with best clinical placement a notable consideration for those wanting to integrate psychological and immunological care through advanced psychiatric nursing roles.

Best Scientists Citing Mark K. Louder

Trending Scientists